The FDA Should Eliminate the Ambiguities in the Current BCS Biowaiver Guidance and Make Public the Drugs for Which BCS Biowaivers Have Been Granted
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.
1995 • 5,050 citations
Intestinal permeability and its relevance for absorption and elimination
2007 • 270 citations
What is the Objective of the Mass Balance Study? A Retrospective Analysis of Data in Animal and Human Excretion Studies Employing Radiolabeled Drugs
2007 • 217 citations
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
2008 • 137 citations
Biopharmaceutics Classification of Selected β-Blockers: Solubility and Permeability Class Membership
2007 • 90 citations
Permeability classification of representative fluoroquinolones by a cell culture method
2004 • 71 citations
Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: Studies on micronized ethylcellulose for dosage form design (VII)
2004 • 67 citations
The Use of Drug Metabolism for Prediction of Intestinal Permeability
2009 • 49 citations